These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [At Home among Strangers: Is It Possible to Create Hypoimmunogenic Pluripotent Stem Cell Lines?]. Bogomiakova ME; Eremeev AV; Lagarkova MA Mol Biol (Mosk); 2019; 53(5):725-740. PubMed ID: 31661474 [TBL] [Abstract][Full Text] [Related]
4. Hypoimmunogenic Human Pluripotent Stem Cells as a Powerful Tool for Liver Regenerative Medicine. Trionfini P; Romano E; Varinelli M; Longaretti L; Rizzo P; Giampietro R; Caroli A; Aiello S; Todeschini M; Casiraghi F; Remuzzi G; Benigni A; Tomasoni S Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511568 [TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of induced pluripotent stem cells. Zhao T; Zhang ZN; Rong Z; Xu Y Nature; 2011 May; 474(7350):212-5. PubMed ID: 21572395 [TBL] [Abstract][Full Text] [Related]
6. Cardiomyocytes Derived from MHC-Homozygous Induced Pluripotent Stem Cells Exhibit Reduced Allogeneic Immunogenicity in MHC-Matched Non-human Primates. Kawamura T; Miyagawa S; Fukushima S; Maeda A; Kashiyama N; Kawamura A; Miki K; Okita K; Yoshida Y; Shiina T; Ogasawara K; Miyagawa S; Toda K; Okuyama H; Sawa Y Stem Cell Reports; 2016 Mar; 6(3):312-20. PubMed ID: 26905198 [TBL] [Abstract][Full Text] [Related]
7. Molecular imaging of induced pluripotent stem cell immunogenicity with in vivo development in ischemic myocardium. Liu Z; Wen X; Wang H; Zhou J; Zhao M; Lin Q; Wang Y; Li J; Li D; Du Z; Yao A; Cao F; Wang C PLoS One; 2013; 8(6):e66369. PubMed ID: 23840453 [TBL] [Abstract][Full Text] [Related]
8. New Immunosuppressive Cell Therapy to Prolong Survival of Induced Pluripotent Stem Cell-Derived Allografts. Sasaki H; Wada H; Baghdadi M; Tsuji H; Otsuka R; Morita K; Shinohara N; Seino K Transplantation; 2015 Nov; 99(11):2301-10. PubMed ID: 26360665 [TBL] [Abstract][Full Text] [Related]
9. Generation of hypoimmunogenic T cells from genetically engineered allogeneic human induced pluripotent stem cells. Wang B; Iriguchi S; Waseda M; Ueda N; Ueda T; Xu H; Minagawa A; Ishikawa A; Yano H; Ishi T; Ito R; Goto M; Takahashi R; Uemura Y; Hotta A; Kaneko S Nat Biomed Eng; 2021 May; 5(5):429-440. PubMed ID: 34002062 [TBL] [Abstract][Full Text] [Related]
14. Hypoimmunogenic human pluripotent stem cells are valid cell sources for cell therapeutics with normal self-renewal and multilineage differentiation capacity. Chen Y; Zhou Y; Zhou Z; Fang Y; Ma L; Zhang X; Xiong J; Liu L Stem Cell Res Ther; 2023 Jan; 14(1):11. PubMed ID: 36691086 [TBL] [Abstract][Full Text] [Related]
15. Development of PET Imaging to Visualize Activated Macrophages Accumulated in the Transplanted iPSc-Derived Cardiac Myocytes of Allogeneic Origin for Detecting the Immune Rejection of Allogeneic Cell Transplants in Mice. Kashiyama N; Miyagawa S; Fukushima S; Kawamura T; Kawamura A; Yoshida S; Harada A; Watabe T; Kanai Y; Toda K; Hatazawa J; Sawa Y PLoS One; 2016; 11(12):e0165748. PubMed ID: 27930666 [TBL] [Abstract][Full Text] [Related]
16. Generation of Monkey Induced Pluripotent Stem Cell-Derived Cartilage Lacking Major Histocompatibility Complex Class I Molecules on the Cell Surface. Okutani Y; Abe K; Yamashita A; Morioka M; Matsuda S; Tsumaki N Tissue Eng Part A; 2022 Jan; 28(1-2):94-106. PubMed ID: 34182799 [TBL] [Abstract][Full Text] [Related]
17. Hypoimmune induced pluripotent stem cells survive long term in fully immunocompetent, allogeneic rhesus macaques. Hu X; White K; Olroyd AG; DeJesus R; Dominguez AA; Dowdle WE; Friera AM; Young C; Wells F; Chu EY; Ito CE; Krishnapura H; Jain S; Ankala R; McGill TJ; Lin A; Egenberger K; Gagnon A; Michael Rukstalis J; Hogrebe NJ; Gattis C; Basco R; Millman JR; Kievit P; Davis MM; Lanier LL; Connolly AJ; Deuse T; Schrepfer S Nat Biotechnol; 2024 Mar; 42(3):413-423. PubMed ID: 37156915 [TBL] [Abstract][Full Text] [Related]
18. Human Leukocyte Antigen Class I and II Knockout Human Induced Pluripotent Stem Cell-Derived Cells: Universal Donor for Cell Therapy. Mattapally S; Pawlik KM; Fast VG; Zumaquero E; Lund FE; Randall TD; Townes TM; Zhang J J Am Heart Assoc; 2018 Dec; 7(23):e010239. PubMed ID: 30488760 [TBL] [Abstract][Full Text] [Related]
19. Cardiac Regeneration Using Pluripotent Stem Cells and Controlling Immune Responses. Ichimura H; Chino S; Shiba Y Heart Lung Circ; 2023 Jul; 32(7):836-843. PubMed ID: 37029069 [TBL] [Abstract][Full Text] [Related]
20. Characteristic expression of major histocompatibility complex and immune privilege genes in human pluripotent stem cells and their derivatives. Chen HF; Yu CY; Chen MJ; Chou SH; Chiang MS; Chou WH; Ko BS; Huang HP; Kuo HC; Ho HN Cell Transplant; 2015; 24(5):845-64. PubMed ID: 24144439 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]